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Prevalences of sexually transmitted infections in young 
adults and female sex workers in Peru: a national 
population-based survey
César P Cárcamo, Pablo E Campos, Patricia J García, James P Hughes, Geoﬀ  P Garnett, King K Holmes, for the Peru PREVEN study team*
Summary
Background We assessed prevalences of seven sexually transmitted infections (STIs) in Peru, stratiﬁ ed by risk 
behaviours, to help to deﬁ ne care and prevention priorities.
Methods In a 2002 household-based survey of the general population, we enrolled randomly selected 18–29-year-old 
residents of 24 cities with populations greater than 50 000 people. We then surveyed female sex workers (FSWs) in 
these cities. We gathered data for sexual behaviour; vaginal specimens or urine for nucleic acid ampliﬁ cation tests for 
Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; and blood for serological tests for syphilis, 
HIV, and (in subsamples) herpes simplex virus 2 (HSV2) and human T-lymphotropic virus. This study is a registered 
component of the PREVEN trial, number ISRCTN43722548.
Findings 15 261 individuals from the general population and 4485 FSWs agreed to participate in our survey. Overall 
prevalence of infection with HSV2, weighted for city size, was 13·5% in men, 13·6% in women, and 60·6% in FSWs 
(all values in FSWs standardised to age composition of women in the general population). The prevalence of 
C trachomatis infection was 4·2% in men, 6·5% in women, and 16·4% in FSWs; of T vaginalis infection was 0·3% in 
men, 4·9% in women, and 7·9% in FSWs; and of syphilis was 0·5% in men, 0·4% in women, and 0·8% in FSWs. 
N gonorrhoeae infection had a prevalence of 0·1% in men and women, and of 1·6% in FSWs. Prevalence of HIV 
infection was 0·5% in men and FSWs, and 0·1% in women. Four (0·3%) of 1535 specimens were positive for human 
T-lymphotropic virus 1. In men, 65·0% of infections with HIV, 71·5% of N gonorrhoeae, and 41·4% of HSV2 and 
60·9% of cases of syphilis were in the 13·3% who had sex with men or unprotected sex with FSWs in the past year. In 
women from the general population, 66·7% of infections with HIV and 16·7% of cases of syphilis were accounted for 
by the 4·4% who had been paid for sex by any of their past three partners. 
Interpretation Deﬁ ning of high-risk groups could guide targeting of interventions for communicable diseases—
including STIs—in the general Peruvian population.
Funding Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative and US National Institutes of Health.
Introduction
National population-based surveys of sexually trans-
mitted infections (STIs) and sexual behaviours provide 
estimates of population-speciﬁ c prevalences, trends, and 
deter minants.1,2 However, most national surveys have 
been restricted to few STIs and sexual behaviours,3–7 or 
to rural populations.8 We present results of surveys of 
STI prevalences in middle-sized cities in Peru, and of 
patterns of sexual behaviours in random household 
samples of young adult residents and samples of female 
sex workers (FSWs).
Methods
Study design and participants
In 2002, we selected 30 Peruvian cities with populations 
greater than 50 000 people. We excluded Lima because of 
its size, two other cities because of their proximity to Lima, 
and three cities involved in a separate prevention study of 
STIs and HIV—leaving 24 cities for inclusion in our study. 
The study sampling frame of the general-population 
survey used the 1999–2000 precensus household database 
of the Peruvian National Institute of Statistics and 
Informatics (INEI). We deﬁ ned sampling units (clusters) 
as roughly 40 households, providing about ten eligible 
participants per cluster. For each city, we assigned a 
random number to every cluster, sorted them numerically, 
and selected the top 108 clusters (36 each for three 
ﬁ eldworkers). Three of the 2592 neighbourhood clusters 
randomly selected for this survey were judged to be 
dangerous (interviewers would be at risk of being attacked 
or robbed) and not surveyed.
Fieldwork for the general-population survey took 
place between Aug 15, and Nov 15, 2002, in nine 10-day 
periods. Fieldworkers updated household lists of men 
and women aged 18–29 years who had lived in the city for 
at least the past 6 months in every cluster. In clusters with 
more than ten households containing young people, a 
table of random numbers for selection of households was 
used to obtain a random sample of ten. Four clusters 
(40 suitable house holds) were covered per period by each 
ﬁ eldworker. When several household members met our 
inclusion criteria, the individual with the most recent 
Articles
766 www.thelancet.com/infection   Vol 12   October 2012
birthday was selected, and scheduled for interview to 
conﬁ rm eligibility and obtain informed consent. When 
eligibility was not sub sequently conﬁ rmed, the eligible 
person with next most recent birthday was selected. 
Recruitment continued until the quota of 250 women and 
250 men per city was reached or exceeded. Interviewers 
wore white gowns with INEI and PREVEN logos, and 
carried backpacks and coolers containing frozen 
acrylamide gel bags.
Between Nov 7, 2002, and April 22, 2003, local teams 
used key informants (peer FSWs, FSW clients, and 
clinics for FSWs) to map sex work venues in every city, 
such as brothels, bars, discos, hotels, toll booths, 
massage parlours, parks, and streets. The teams selected 
the order for venue visits with random numbers until all 
FSWs identiﬁ ed were recruited, or 200 FSWs had been 
recruited per city, primarily from these venues (80%) 
and also from local government clinics serving FSWs 
(20%). All eligible consenting women aged 14 years or 
older oﬀ ering sex services identiﬁ ed during venue or 
clinic visits were invited to participate. FSW surveyors 
visited new venues when open for sex services until the 
city quota of 200 was reached or exceeded, or the survey 
period ended.
The research team obtained written approval from the 
Peruvian Ministry of Health, and verbal approval from 
health directors of all regions surveyed to use Ministry 
of Health laboratories and counselling staﬀ  for the 
survey. Participants provided verbal informed consent, 
without personal identiﬁ ers. Institutional review boards 
at the University of Washington (Seattle, WA, USA), the 
Universidad Peruana Cayetano Heredia (Lima, Peru), 
and the US Naval Medical Research Unit Number 6 
(NAMRU-6; Lima, Peru) approved the protocol, consent 
forms, and instruments. The institutional review boards 
approved inclusion of girls aged 14–17 years involved in 
sex work because they were ﬁ nancially independent 
from their parents, sexually active, and as minors were 
often excluded from Ministry of Health clinical services 
for FSWs. Young adult survey participants received 
study caps and T-shirts; FSW survey participants 
received free condoms.
Procedures
For general-population surveys, female health profes-
sionals (ie, nurses, midwives, and medical doctors) with 
venepuncture experience took a 9-day course of lectures, 
demonstrations, and supervised role-playing of inter-
viewing, specimen collection and coding, ethics, STIs, 
map interpretation, participant selection, and informed 
consent procedures. Seven regional coordinators, a na-
tional supervisor, three interviewers, and one supervisor 
for every city were selected on the basis of course 
performance. We similarly trained and selected inter-
viewers and supervisors for FSW surveys; every ﬁ eld 
team included an FSW peer-educator, a counsellor–
interviewer, and a physician or midwife.
Laboratory technicians designated by local health 
authorities received training in specimen processing, 
labelling, storage, shipping, and Trichomonas vaginalis 
cultures. Staﬀ  from the University of Washington 
provided supervision, quality assurance, and Gen-Probe 
Aptima Combo 2 assays for quality control.
Face-to-face interviews addressed demographics, 
household characteristics, travel and migration, labour, 
and marriage. Subsequent private, self-administered 
question naires of participants from the general popu-
lation explored sexual behaviours; completed question-
naires were sealed in envelopes, and placed into locked 
voting bags9 to ensure anonymity.
Men from the general population provided 15 mL ﬁ rst-
void urine and the women provided self-obtained vaginal 
swabs (SOVS), with one polyester–plastic swab and then 
two cotton–wooden swabs. Interviewers promptly placed 
polyester SOVS into cryovials, and inoculated the ﬁ rst 
cotton swab into an InPouch TV system (BioMed 
Diagnostics, White City, OR, USA) for T vaginalis culture. 
Women from the general population who did not provide 
SOVS were asked for 15 mL ﬁ rst-void urine samples. For 
FSWs, a polyester cervical swab and two cotton vaginal 
swabs were obtained during speculum examination. 
Venous blood was collected from consenting participants. 
A subset of the general-population participants (100% of 
individuals with a cohabiting sex partner and 10% random 
sample of others) and an 8·5% random sample (size of 
sample determined by number of test kits available) of 
FSWs underwent testing for herpes simplex virus 2 
(HSV2). To obtain the random samples, we assigned ran-
dom numbers to individuals from the general population 
and to FSWs who gave blood, ordered them numerically, 
and selected individuals from the top of the list.
Urine, polyester swabs, and blood were transported 
inside coolers to the local laboratory within 4 h of 
collection. T vaginalis cultures were transported at am-
bient temperature. Consent forms, face-to-face ques-
tionnaires, referral cards, and samples were labelled with 
alphanumeric codes and barcodes. Self-completed 
questionnaires were labelled with bar codes.
Local laboratory staﬃ  ng was scheduled whenever 
speci mens were obtained; urine and serum were 
promptly divided into aliquots in vials and frozen at 
–20°C. Frozen urine and serum aliquots and polyester 
swabs were sent weekly to Lima laboratories in Styrofoam 
coolers wrapped in metal. T vaginalis culture results were 
sent to Lima monthly.
Temperature within coolers on arrival in Lima was 
usually less than 0°C and never more than 1°C. 1 mL of 
2-sucrose phosphate medium10 was added to vials con-
taining dry polyester swabs, which was then mixed, 
divided into aliquots, and stored at −20°C until testing by 
Cobas Amplicor for Neisseria gonorrhoeae and Chlamydia 
trachomatis. All specimens positive for N gonorrhoeae, 
samples of specimens positive for C trachomatis, and all 
specimens with equivocal results per manufacturer’s 
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instructions went to the University of Washington for 
conﬁ rmatory tests with the Aptima Combo 2 assay. Spe-
cimens in 2-sucrose-phosphate also underwent Aptima 
testing for T vaginalis. We tested specimens for syphilis 
serology with RPR nosticon II (Organon Teknika, Boxtel, 
Netherlands), judging results positive when rapid plasma 
reagin measurements were 1:8 or more, with 
conﬁ rmation by Serodia TPPA (Fujirebio, Tokyo, Japan). 
We used Uni-Form II Ag/Ab (Biomerieux-Vironostika, 
Durham, NC, USA) ELISA for HIV serology and New 
LAV Blot I (Bio-Rad, Hercules, CA, USA) for conﬁ rmation. 
The ﬁ rst 1530 sera specimens (number determined by 
number of test kits available) from the general population 
were tested for human T-lymphotropic virus seropositivity 
by ELISA (Vironostika, Durham, NC, USA), with western 
blot 2·4 (Genelabs Diagnostics, Science Park, Singapore). 
We used ELISA testing for HSV2 (HerpeSelect HSV-2, 
Focus Technologies, Cypress, CA, USA); index values of 
3·5 or more were deemed positive. All diagnostic tests 
were done in accordance with the manufacturer’s recom-
mended procedures.
Participants who provided specimens received HIV 
coun selling booklets.11 Results for syphilis, C trachomatis, 
N gonorrhoeae, HIV, and T vaginalis culture were printed 
and distributed to predeﬁ ned local STI clinics to which 
participants from the general population had been 
referred. To distribute results to FSWs, clinic counsellors 
returned to sex work venues. Results, counselling, and 
treatment for STIs, and referral for care for patients 
with HIV (after informed consent) were provided 
anonymously by matching sample codes with each 
participant’s referral card code.
Statistical analysis
Face-to-face questionnaires were checked daily for 
consistency and completeness, corrected locally when 
necessary, and then sent to Lima for data entry. Self-
completed questionnaires were sent to Lima without 
local validation to ensure conﬁ dentiality. We entered 
general-population data with an SQL program. All FSW 
survey data were double entered with EpiInfo 
(version 3.3). All self-completed questionnaires and 5% 
Households 
selected
Households 
excluded*
Selected 
person absent
Selected person identiﬁ ed and invited to participate
Total Refused Accepted
Total Provided 
questionnaire data 
Provided biological 
samples 
Arequipa 970 113 (12%) 11 846 82 (10%) 764 (90%) 764 607 (79%)
Ayacucho 969 259 (27%) 13 697 40 (6%) 657 (94%) 657 538 (82%)
Barranca 990 168 (17%) 6 816 114 (14%) 702 (86%) 702 537 (76%)
Cajamarca 995 197 (20%) 3 795 131 (16%) 664 (84%) 664 518 (78%)
Cerro de Pasco 765 106 (14%) 2 657 43 (7%) 614 (93%) 614 566 (92%)
Chimbote 980 261 (27%) 21 698 26 (4%) 672 (96%) 672 564 (84%)
Chincha 925 176 (19%) 0 749 30 (4%) 719 (96%) 719 523 (73%)
Cusco 995 334 (34%) 1 660 56 (8%) 604 (92%) 604 563 (93%)
Huancayo 971 207 (21%) 19 745 67 (9%) 678 (91%) 678 537 (79%)
Huanuco 969 288 (30%) 2 679 61 (9%) 618 (91%) 618 516 (83%)
Huaraz 878 154 (18%) 14 710 76 (11%) 634 (89%) 634 539 (85%)
Ica 866 281 (32%) 1 584 20 (3%) 564 (97%) 564 521 (92%)
Ilo 903 110 (12%) 59 734 152 (21%) 582 (79%) 582 550 (94%)
Iquitos 780 188 (24%) 0 592 11 (2%) 581 (98%) 581 531 (91%)
Juliaca 954 250 (26%) 5 699 91 (13%) 608 (87%) 608 572 (94%)
Pisco 885 242 (27%) 3 640 59 (9%) 581 (91%) 580 546 (94%)
Piura 892 213 (24%) 5 674 33 (5%) 641 (95%) 641 558 (87%)
Pucallpa 993 348 (35%) 3 642 32 (5%) 610 (95%) 610 552 (90%)
Puno 989 234 (24%) 14 741 81 (11%) 660 (89%) 660 583 (88%)
Sullana 984 197 (20%) 12 775 124 (16%) 651 (84%) 651 524 (80%)
Tacna 861 215 (25%) 0 646 48 (7%) 598 (93%) 598 552 (92%)
Talara 967 182 (19%) 29 756 192 (25%) 564 (75%) 564 522 (92%)
Tarapoto 899 236 (26%) 5 658 19 (3%) 639 (97%) 639 544 (85%)
Tumbes 956 282 (29%) 0 674 18 (3%) 656 (97%) 656 536 (82%)
Total 22 336 5241 (23%) 228 16 867 1606 (10%) 15 261 (90%) 15 260 13 099 (86%)
Data are n or n (%). *Excluded after selection because eligibility of members was not conﬁ rmed or because the quota for their sex had already been reached. 
Table 1: Participation in the general population survey by city
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of face-to-face questionnaires were double entered. We 
used 5% of face-to-face questionnaires to allow us to test 
the hypothesis that the frequency of errors in any one 
variable was less than 2% with 95% CIs. For face-to-face 
question naires, error frequency was less than 1%.
We analysed data with STATA (version 8.2). To account 
for diﬀ er ences in general-population sampling prob-
abilities in cities of various population sizes, we present 
weighted prevalences when totalling prevalences of STIs 
for all cities combined. City-level estimates of general-
popu lation prevalences of HSV2 are weighted to account 
for test subsampling. To account for diﬀ erences in age 
composition of FSWs and women from the general 
population surveyed, we calculated age-standardised STI 
prevalences for FSWs by excluding those younger than 
18 years or older than 29 years, and weighted remaining 
FSW data in line with proportions of women from the 
general population in every age category. We calculated 
prevalence ratios with an unweighted generalised linear 
model with log link and adjustment for clustering and 
age. We calculated p values from the same regression or 
by exact logistic regression for very rare diseases. 
This study is a registered component of the PREVEN 
trial, number ISRCTN43722548.
Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data inter pretation, or 
writing of the report. The corresponding author had full 
access to all data in the study and had ﬁ nal responsibility 
for the decision to submit for publication.
Results
Of 15 261 individuals from the general population who 
agreed to participate in our survey (table 1), 43 (0·3%) left 
the self-completed questionnaire blank. 11 483 individuals 
Serological test results Nucleic acid ampliﬁ cation testing of urine
Syphilis* HSV2† HIV Neisseria gonorrhoeae Chlamydia trachomatis Trichomonas vaginalis
Coastal
Barranca 3/213 (1%) 59 (8%) 2/213 (1%) 0/267 10/267 (4%) 0/267
Chimbote 1/238 (<1%) 47 (9%) 0/238 0/287 8/287 (3%) 0/288
Chincha 1/231 (<1%) 30 (28%) 2/230 (1%) 1/256 (<1%) 8/256 (3%) 0/256
Ica 4/232 (2%) 48 (4%) 1/232 (<1%) 0/255 6/256 (2%) 1/256 (<1%)
Ilo 0/232 62 (2%) 0/231 0/251 10/251 (4%) 1/265 (<1%)
Pisco 0/259 52 (8%) 0/259 0/265 10/265 (4%) 3/281 (1%)
Piura 2/234 (<1%) 51 (1%) 0/234 0/278 3/279 (1%) 0/280
Sullana 0/215 51 (10%) 1/215 (1%) 0/242 11/243 (5%) 0/268
Tacna 0/243 36 (5%) 1/243 (<1%) 0/244 10/244 (4%) 1/264 (<1%)
Talara 1/223 (<1%) 45 (18%) 1/224 (<1%) 1/255 (<1%) 12/255 (5%) 1/255 (<1%)
Tumbes 0/225 45 (22%) 1/225 (<1%) 1/265 (<1%) 5/265 (2%) 0/265
Andean
Arequipa 0/213 26 (9%) 1/213 (1%) 0/273 5/273 (2%) 0/275
Ayacucho 0/259 51 (8%) 0/259 0/270 11/270 (4%) 1/272 (<1%)
Cajamarca 0/219 61 (5%) 0/219 0/231 7/231 (3%) 0/258
Cerro de Pasco 0/252 45 (1%) 1/252 (<1%) 0/253 14/253 (6%) 0/280
Cuzco 1/252 (<1%) 60 (19%) 0/252 0/284 12/285 (4%) 2/286 (1%)
Huancayo 0/219 40 (5%) 0/219 0/255 11/255 (4%) 2/256 (1%)
Huaraz 0/225 42 (7%) 0/225 0/265 13/265 (5%) 1/265 (<1%)
Juliaca 0/261 50 (0%) 0/261 1/244 (<1%) 12/244 (5%) 2/289 (1%)
Puno 0/265 60 (<1%) 2/265 (1%) 0/247 14/247 (6%) 2/300 (1%)
Amazonian
Huanuco 0/210 59 (9%) 0/210 2/234 (1%) 13/235 (6%) 4/251 (2%)
Iquitos 4/252 (2%) 51 (38%) 4/252 (2%) 0/267 21/267 (8%) 1/268 (<1%)
Pucallpa 5/260 (2%) 55 (34%) 5/260 (%2) 1/286 (<1%) 15/286 (5%) 0/286
Tarapoto 6/250 (2%) 50 (24%) 0/250 2/258 (1%) 8/258 (3%) 0/267
Total 28/5682 (1%) 1176 22/5681 (<1%) 9/6232 (<1%) 249/6237 (4%) 22/6498 (<1%)
Weighted prevalence‡ 0·5% 13·5% 0·5% 0·1% 4·2% 0·3%
Data are number positive/number tested (%) unless otherwise stated. HSV2=herpes simplex virus 2. *Rapid plasma reagin 1:8 or higher, Treponema pallidum particle 
agglutination positive. †HSV2 testing was done with a subset of sera available, and thus city prevalences of seropositivity are further weighted accordingly and only 
denominators are shown. ‡Prevalences weighted by city size. 
Table 2: Prevalences of sexually transmitted infections in men aged 18–29 years by region and city
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(75·2%) provided blood. Of 7486 men, 6500 (86·8%) 
provided urine. Of 7775 women, 5924 (76·2%) provided 
SOVS and 588 others (7·6%) provided urine. 4485 FSWs 
participated. The FSW participation rate was 95% in the 
ﬁ ve cities where it was measured. Question naire data are 
available from 4413 (98·4%) FSWs, blood from 
4428 (98·7%), and cervical swabs (for C trachomatis and 
N gonorrhoeae) and vaginal swabs (for T vaginalis) from 
4280 (95·4%).
Frequencies of STIs varied between cities (tables 2–4). 
In three cities in the Amazon jungle (Tarapoto, Iquitos, 
and Pucallpa) the prevalence of STIs was notably higher 
than in other cities, particularly in men (table 2).
6069 men (81·1%) and 5623 women (72·3%) reported 
previous sexual intercourse. Prevalences were generally 
lower in participants denying sexual experience than in 
those reporting previous sexual intercourse (table 5). 
Only four (0·3%) of 1530 sera specimens from individuals 
from the general population were positive for human 
T-lymphotropic virus 1 (two men, two women), and none 
were positive for human T-lymphotropic virus 2.
Of sexually experienced men from the general 
population, 460 (7·6%) reported sex with another man 
and 447 (7·4%) unprotected sex with an FSW within the 
past year. Of 5607 sexually experienced women from the 
general popula tion for whom responses to the three 
relevant questions were available, 233 (4·2%) reported 
receiving money in exchange for sex from any of their 
past three sex partners. In most risk groups of men and 
women from the general population and in FSWs, HSV2 
seropositivity had the highest prevalence, then 
C trachomatis infection, and then T vaginalis infection in 
women (ﬁ gure, table 6). Prevalences of the various STIs 
clearly diﬀ er by risk group (table 6).
Additionally, STI prevalence ratios showed diﬀ erences 
between risk subgroups (appendix). Compared with 
Serological test results Nucleic acid ampliﬁ cation testing of urine or vaginal swab
Syphilis* HSV2† HIV Neisseria gonorrhoeae Chlamydia trachomatis Trichomonas vaginalis
Coastal
Barranca 0/230 55 (4%) 0/230 1/268 (<1%) 17/267 (6%) 14/263 (5%)
Chimbote 0/237 52 (16%) 0/237 0/271 12/271 (4%) 13/270 (5%)
Chincha 2/246 (1%) 63 (22%) 0/247 0/263 17/263 (7%) 21/262 (8%)
Ica 1/243 (<1%) 49 (19%) 0/243 0/262 8/261 (3%) 12/262 (5%)
Ilo 0/254 68 (6%) 0/254 0/276 15/276 (5%) 6/276 (2%)
Pisco 0/228 61 (9%) 1/228 (<1%) 0/258 17/259 (7%) 24/260 (9%)
Piura 0/243 68 (3%) 0/243 0/274 12/274 (4%) 12/273 (4%)
Sullana 0/218 64 (14%) 0/218 0/249 9/249 (4%) 6/254 (2%)
Tacna 2/260 (1%) 51 (14%) 0/260 1/283 (<1%) 22/283 (8%) 11/283 (4%)
Talara 1/242 (<1%) 67 (10%) 0/242 1/263 (<1%) 15/264 (6%) 17/261 (7%)
Tumbes 0/242 72 (17%) 0/242 1/266 (<1%) 9/268 (3%) 6/268 (2%)
Andean
Arequipa 0/205 48 (9%) 0/204 0/296 12/296 (4%) 6/298 (2%)
Ayacucho 0/253 60 (9%) 0/253 0/265 19/264 (7%) 16/262 (6%)
Cajamarca 0/219 51 (2%) 0/219 0/250 15/250 (6%) 17/254 (7%)
Cerro de Pasco 0/270 64 (12%) 0/270 0/282 14/283 (5%) 24/285 (8%)
Cuzco 2/244 (1%) 69 (2%) 0/244 0/272 16/272 (6%) 15/272 (6%)
Huancayo 1/244 (<1%) 49 (9%) 0/244 0/272 24/273 (9%) 18/272 (7%)
Huaraz 0/247 61 (5%) 0/247 1/272 (<1%) 19/272 (7%) 18/270 (7%)
Juliaca 0/237 79 (1%) 0/237 0/268 26/268 (10%) 16/272 (6%)
Puno 0/235 64 (5%) 0/235 1/278 (<1%) 21/278 (8%) 9/282 (3%)
Amazonian
Huanuco 2/238 (1%) 47 (8%) 1/238 (<1%) 0/263 16/262 (6%) 18/263 (7%)
Iquitos 4/255 (2%) 66 (36%) 0/255 0/257 26/258 (10%) 14/260 (5%)
Pucallpa 2/245 (1%) 67 (33%) 1/245 (<1%) 0/258 29/258 (11%) 12/260 (5%)
Tarapoto 3/264 (1%) 91 (17%) 0/264 1/273 (<1%) 24/273 (9%) 11/275 (4%)
Total 20/5799 (<1%) 1486 3/5799 (<1%) 7/6439 (<1%) 414/6442 (6%) 336/6457 (5%)
Weighted prevalence‡ 0·4% 13·6% 0·1% 0·1% 6·5% 4·9%
Data are number positive/number tested (%) unless otherwise stated. HSV2=herpes simplex virus 2. *Rapid plasma reagin 1:8 or higher, Treponema pallidum particle 
agglutination positive. †HSV2 testing was done with a subset of sera available, and thus city prevalences of seropositivity are further weighted accordingly and only 
denominators are shown. ‡Prevalences weighted by city size. 
Table 3: Prevalences of sexually transmitted infections in women aged 18–29 years from the general population by region and city
See Online for appendix
Articles
770 www.thelancet.com/infection   Vol 12   October 2012
sexually experienced women from the general population 
not receiving money for sex, FSWs had signiﬁ cantly 
higher age-adjusted prevalences of N gonorrhoeae 
(prevalence ratio 12·31, p=0·004), HSV2 (3·12, p<0·001), 
syphilis (3·04, p<0·001), C trachomatis (2·09, p<0·001), 
and T vaginalis (1·56, p<0·001; appendix). Furthermore, 
prevalence of syphilis in women from the general 
population receiving money for sex from any of the past 
three partners was signiﬁ cantly higher (4·77, p=0·016) 
and prevalence of HIV was also increased (40·17, 
p=0·010; appendix) compared with sexually experienced 
women who did not receive money for sex. Women 
denying sexual experience had lower prevalences of all 
STIs than did sexually experienced women, although the 
diﬀ erence was signiﬁ cant only for infection with 
C trachomatis (0·19, p<0·001), HSV2 (0·25, p=0·007), 
and T vaginalis (0·57, p<0·001; appendix).
Compared with sexually experienced men reporting 
neither sex with men nor unprotected sex with FSWs 
during the past year, men reporting sex with men 
had signiﬁ cantly higher prevalences of HIV, syphilis, 
N gonorrhoeae, and HSV2 (appendix). Exclusively hetero-
Men Women
Sexually 
experienced 
(n=6069)
Not sexually 
experienced 
(n=1417)
Sexually 
experienced 
(n=5623)
Not sexually 
experienced 
(n=2152)
Herpes simplex virus 2* 14·6% 6·6% 17·4% 1·3%
HIV 0·4% 0·2% 0·1% 0
Syphilis† 0·5% 0·5% 0·4% 0·2%
Chlamydia trachomatis 4·6% 1·2% 7·8% 2·0%
Trichomonas vaginalis 0·4% 0 5·8% 3·3%
Neisseria gonorrhoeae 0·1% 0·2% 0·1% 0·1%
*Weighted values. †Rapid plasma reagin 1:8 or higher, Treponema pallidum particle agglutination positive. 
Table 5: Prevalences of infections
Serological test results Nucleic acid ampliﬁ cation testing of vaginal swabs
Syphilis* HSV2† HIV Neisseria gonorrhoeae Chlamydia trachomatis Trichomonas vaginalis
Coastal
Barranca 3/170 (2%) 14/18 (78%) 0/168 4/141 (3%) 12/141 (9%) 8/136 (5%)
Chimbote 6/197 (3%) 32/36 (89%) 2/199 (1%) 1/200 (1%) 21/200 (11%) 14/192 (7%)
Chincha 0/196 5/6 (83%) 3/199 (2%) 0/200 8/200 (4%) 11/186 (6%)
Ica 0/198 6/9 (67%) 1/200 (1%) 0/198 11/198 (6%) 9/184 (5%)
Ilo 0/200 5/11 (45%) 0/200 2/200 (1%) 32/200 (16%) 8/196 (4%)
Pisco 3/148 (2%) 3/7 (43%) 1/148 (1%) 0/148 16/148 (11%) 17/145 (12%)
Piura 2/193 (1%) 8/11 (73%) 4/193 (2%) 3/171 (2%) 17/171 (10%) 14/161 (9%)
Sullana 2/197 (1%) 14/27 (52%) 0/200 1/197 (1%) 24/197 (12%) 22/192 (11%)
Tacna 0/172 6/10 (60%) 1/205 (1%) 0/196 39/196 (20%) 15/193 (8%)
Talara 0/152 5/12 (42%) 2/143 (1%) 0/156 21/156 (13%) 12/155 (8%)
Tumbes 2/72 (3%) 10/12 (83%) 2/74 (3%) 1/57 (2%) 6/57 (11%) 3/53 (6%)
Andean
Arequipa 1/198 (1%) 4/10 (40%) 1/201 (1%) 1/188 (1%) 42/188 (22%) 21/194 (11%)
Ayacucho 2/143 (1%) 9/15 (60%) 1/147 (1%) 1/147 (1%) 18/147 (12%) 8/143 (6%)
Cajamarca 2/177 (1%) 9/12 (75%) 0/184 0/196 32/196 (16%) 21/184 (11%)
Cerro de Pasco 1/194 (1%) 3/17 (18%) 0/199 0/200 40/200 (20%) 24/196 (12%)
Cusco 1/208 (1%) 10/17 (59%) 0/208 0/200 21/200 (11%) 18/194 (9%)
Huancayo 1/194 (1%) 5/10 (50%) 0/196 2/185 (1%) 24/185 (13%) 7/181 (4%)
Huaraz 1/143 (1%) 8/11 (73%) 1/140 (1%) 1/138 (1%) 22/138 (16%) 12/137 (9%)
Juliaca 1/194 (1%) 1/11 (9%) 0/197 2/177 (1%) 29/177 (16%) 8/171 (5%)
Puno 0/200 4/14 (29%) 0/201 3/183 (2%) 32/183 (17%) 13/182 (7%)
Amazonian
Huanuco 7/203 (3%) 16/21 (76%) 1/202 (1%) 7/204 (3%) 46/204 (23%) 40/194 (21%)
Iquitos 9/197 (5%) 26/26 (100%) 3/200 (2%) 20/198 (10%) 36/198 (18%) 17/175 (10%)
Pucallpa 7/195 (4%) 31/32 (97%) 3/200 (2%) 8/181 (4%) 36/181 (20%) 17/171 (10%)
Tarapoto 5/173 (3%) 23/26 (89%) 3/159 (2%) 12/202 (6%) 48/202 (24%) 24/190 (13%)
Total 56/4314 (1%) 257/381 (67%) 29/4363 (1%) 69/4263 (2%) 633/4263 (15%) 363/4105 (9%)
Age-adjusted prevalence‡ 0·8% 60·6% 0·5% 1·6% 16·4% 7·9%
Data are number positive/number tested (%) unless otherwise stated. HSV2=herpes simplex virus 2. *Rapid plasma reagin 1:8 or higher, Treponema pallidum particle 
agglutination positive. †HSV2 testing done with a self-weighted subset of sera available. ‡Restricted to 18–29-year-old female sex workers, and standardised to the age 
composition of women in the general populations survey (age compositions in the two groups were very similar). 
Table 4: Prevalences of sexually transmitted infections in female sex workers by region and city
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sexual men reporting unprotected sex with FSWs during 
the past year had signiﬁ cantly higher prevalences of 
N gonorrhoeae and HIV, and men denying sexual experi-
ence had signiﬁ cantly lower prevalences of C trachomatis 
and T vaginalis infection than did sexually experienced 
individuals not reporting unprotected sex with FSWs 
(appendix). In men and women from the general popu-
lation denying sexual experience, HSV2 seropositivity, 
C trachomatis, and (in women only) T vaginalis, were 
nonetheless occasionally reported (appendix).
Of 5405 sexually experienced men from the general 
population for whom laboratory results were available, 
432 (8·0%) reported sex with men and 284 (5·3%) 
exclusively heterosexual men reported unprotected sex 
with FSWs in the past year. These men accounted for 
65·0% of infections with HIV, 60·9% of cases of syphilis, 
71·5% of infections with N gonorrhoeae, and 41·4% of 
infections with HSV2, but only 14·8% of C trachomatis 
and 4·5% of T vaginalis infections. Of 5011 sexually 
experienced women from the general population for 
Men Women
Without 
sexual 
experience 
(n=1129)
Had sex with 
men in past 
year (n=432)
Had unprotected 
sex with FSW in 
past year 
(n=284)*
Others with 
sexual 
experience 
(n=4689)
From general 
population without 
sexual experience 
(n=1512)
From general 
population and paid for 
sex by any of last three 
partners (n=219)
Others from general 
population with sexual 
experience (n=4792)
All FSWs 
(n=4463)
Age-adjusted 
sample of 
FSWs 
(n=4463)† 
Neisseria gonorrhoeae 0·19% 0·73% 0·73% 0·04% 0·07% 0·00% 0·13% 1·62% 1·64%
HIV 0·22% 2·52% 1·13% 0·17% 0·00% 1·04% 0·02% 0·66% 0·52%
Syphilis‡ 0·54% 3·02% 0·75% 0·22% 0·16% 1·55% 0·35% 1·30% 0·78%
Trichomonas vaginalis 0 0·00% 0·36% 0·45% 3·29% 7·83% 5·70% 8·84% 7·87%
Chlamydia trachomatis 1·21% 6·02% 3·64% 4·49% 1·89% 10·23% 7·68% 14·85% 16·41%
HSV2§ 6·63% 44·66% 17·47% 10·00% 1·29% 17·60% 17·42% 67·45% 60·58%
Patients in each risk category are those who provided questionnaire data and had at least one laboratory test result. FSW=female sex worker. HSV2=herpes simplex virus 2. *Excludes individuals who also had sex 
with men. †18–29-year-old FSWs, standardised to the age composition of women in the general-population survey. ‡Rapid plasma reagin 1:8 or higher, Treponema pallidum particle agglutination positive. 
§HSV2 seroprevalence is weighted by city size and sampling probability.
Table 6: Prevalences of sexually transmitted infections by risk category
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All FSWsOther sexually
experienced 
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Age-adjusted 
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HSV2*
Chlamydia trachomatis
Trichomonas vaginalis
Syphilis†
HIV
Neisseria gonorrhoeae
Figure: Prevalences of sexually transmitted infections by subgroups of men and women aged 18–29 years from the general population, in all FSWs, and in age-adjusted FSWs
Age-adjusted data for FSWs aged 18–29 years were weighted for comparison with women from the general population. FSW=female sex worker. HSV2=herpes simplex virus 2. *HSV2 testing was done 
with a subset of sera available, and thus city prevalences of seropositivity are further weighted accordingly. †Rapid plasma reagin 1:8 or higher, Treponema pallidum particle agglutination positive. 
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whom laboratory results were available, 219 (4·4%) 
reported sex for money with any of their past three 
partners. These women accounted for 66·7% of infections 
with HIV and 16·7% of cases of syphilis, but only 0·1% of 
N gonorrhoeae, 5·1% of HSV2, 5·7% of C trachomatis, and 
5·9% of T vaginalis infections.
Discussion
We have shown that, even in household samples, women 
reporting receiving money for sex accounted for most 
infections with HIV in women from the general 
population. Men who have sex with men and 
heterosexual men reporting unprotected sex with FSWs 
accounted for most HIV and N gonorrhoeae infections 
and cases of syphilis in men from the general population. 
Diﬀ erences between the sexes in the general population 
for syphilis and HIV infection were largely a result of 
concentration of these diseases in men who have sex 
with men. Survey participation rates were high; detailed 
sociobehavioral and STI test data allowed us to 
deﬁ nitively show that STI prevalences diﬀ er greatly 
between risk groups. These data, when coupled with 
large numbers of sexual partners for individuals in high-
risk groups, clearly suggest that targeted, strong 
preventive interventions are needed in the general 
population and for FSWs. The results provided baseline 
data for an urban community-randomised trial of STI 
prevention—the Peru PREVEN study.12
Investigators of Latin American studies in 1991 and 1992 
(of 18–30-year-old patients undergoing routine health 
examinations in Lima, Peru, and 17–30-year-old sex 
workers in Mexico City, Mexico) recorded HSV2 
seroprevalences13 that are similar to the values reported by 
us for young adults and FSWs in Peru. Infections with 
N gonorrhoeae and HIV and cases of syphilis were absent 
or nearly absent in many Peruvian cities, even in FSWs. 
Peru’s approach to control of these STIs, at least in 
heterosexual individuals, warrant continuation. The high 
prevalences of C trachomatis and T vaginalis call for 
innovative improvements in control of both infections. 
Even higher prevalences of syphilis, C trachomatis, and 
(for women) of T vaginalis than in our study have been 
reported in samples of socially marginalised men (eg, 
gang members) and women in three coastal cities of 
Peru,14–16 suggesting that preventive interventions for such 
populations will also be important, although challenging 
to implement. Reasons for substantially higher rates of 
STIs in certain cities—particularly Amazonian cities—
will be further explored in community-level analyses.
The PREVEN surveys extend comprehensive surveillance 
results from US studies (panel) to Latin America. PREVEN 
complements the US studies because of the high rates of 
participation and completion of questionnaires; the 
assessment of prevalence not only by age, sex, and (in 
men) sexual orientation, but also by region and history of 
sex for money; and the surveying of FSWs. 
We excluded Lima, which has had increased rates of 
HIV infection in men who have sex with men26 and post-
partum women;27 we also excluded rural populations. 
PREVEN study leaders have previously surveyed STIs in 
rural women throughout Peru.28 Our general-population 
survey cannot be generalised to populations that are 
younger or older than ours was, to non-household-based 
populations, or to individuals living in a city for less 
than 6 months. Exclusion of non-household populations 
has been argued to have little eﬀ ect on national HIV 
seroprevalence estimates for household surveys;29 house-
hold-based HIV prevalence surveys could provide useful 
incidence estimates.30
Panel: Research in context
Systematic review
We used PubMed to search Medline with the term “population based survey prevalence” in 
combination with each pathogen we studied. We identiﬁ ed reports of surveys temporally 
overlapping with the period 2000–03 published in English in which participants were 
speciﬁ cally tested for several sexually transmitted infections (STIs), including the National 
Health and Nutrition Exam Survey (NHANES) and National Longitudinal Study of 
Adolescent Health (Add Health) in the USA. We did not include several other population-
based surveys that focused on only Chlamydia trachomatis, HIV infection, or history of STIs. 
Population-based data for STIs other than C trachomatis or HIV infections were scarce, except 
in the USA and Peru. During the time of our surveys, NHANES and Add Health examined 
prevalences of several STIs in young adults in the USA. In 5767 individuals aged 18–49 years 
in the 2001–04 NHANES, syphilis seroprevalence (rapid plasma reagin titre 1:8 or more) was 
0·08%.17 The 1999–2004 NHANES used immunodot assays for herpes simplex virus 2 
(HSV2) in 2412 adults aged 20–29 years, and showed that prevalence of HSV2 seropositivity 
in men was 5·6% and in women 15·6%.18 In the 2001–04 NHANES, prevalence of 
Trichomonas vaginalis in urine by PCR was 2·2% in 20–29-year-old women.3 In the 
1999–2002 NHANES,19 ligase chain reaction tests of urine showed that prevalence of 
Neisseria gonorrhoeae was 0·21% in men and women combined, and prevalence of 
C trachomatis was 1·9% in women and 3·2% in men. Similarly, in wave 3 (2001–02) of Add 
Health—a sample of 14 322 18–26-year-old adults—prevalence of C trachomatis by ligase 
chain reaction was 4·7% in women and 3·1% in men, and prevalence of N gonorrhoeae was 
0·42% in women and 0·44% in men.20 Prevalence of T vaginalis was 2·8% in women and 1·7% 
in men.21 HIV prevalence measured with oral mucosal transudate assay was 0·1% in men and 
0·09% in women, but only 0·02% in individuals not classiﬁ ed as non-Hispanic black.22 A 
national stratiﬁ ed probability sample of 3426 individuals aged 20–64 years surveyed in 
1999–2000 in China with urine ligase chain reaction23 established that prevalence of 
N gonorrhoeae was 0·08% in women and 0·02% in men. Prevalence of C trachomatis was 
2·7% in women and 3·3% in men aged 20–34 years. The Natsal 2000 stratiﬁ ed probability 
survey in Britain (1999–2001) showed that prevalence of C trachomatis measured with urine 
ligase chain reaction was 3·0% in men 25–34-years-old, and 3·0% in women aged 
18–24 years.24 Finally, in 2011, WHO estimated prevalences of STIs with 2002–05 data from 
South and Central America and the Caribbean for 15–49-year-old women and men.25
Interpretation
We have reported prevalences of STIs that are generally higher than are those that have been 
recorded previously. However, the new prevalence estimates reported by WHO are generally 
similar to what we have reported, although frequency of T vaginalis and N gonorrhoeae 
infection was lower in our study than the WHO estimates. Our results for subgroups and 
those from NHANES and Add Health, showing that a small number of high risk groups 
account for most cases of STIs, could guide targeting of interventions in the future in similar 
settings. Additionally, our ﬁ nding that STIs are more common in Amazonian cities indicates 
that preventive interventions for individuals who live in these regions are important.
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Overall, national surveys can inform national health 
care and prevention policies, and could motivate similar 
sur veillance elsewhere. Global burden of disease analyses 
rely on such data. Deﬁ nition of risk factors in such 
surveys, and concurrent surveys from high-risk popu-
lations, will be increasingly important for targeting of 
interventions for communicable diseases.
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